Although the literature on the chemokine biology of GBS is relatively sparse, several studies suggest potential roles for CCL2/CCR2, CCL5/CCR5 and CXCL10/CXCR3 signaling in AIDP pathogenesis [3]. The gene discussed is CXCR3; the disease is Guillain-Barre syndrome.